SCI (4119.TW) monthly revenue, September 2026

SCI reported revenue of NT$0.16bn for September 2026, up 9.7% from the previous month and up 33.1% from a year earlier. Year-to-date revenue was NT$1.15bn, up 16.6% year on year. It ranked 41 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.

中文版

MonthRevenue NT$bnMoM %YoY %
September 20260.169.733.1